• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症标志物在溃疡性结肠炎急性发作中的作用:CRP 水平多高提示重度结肠炎?

Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?

机构信息

Department of Gastroenterology & Hepatology, Royal Brisbane and Women's Hospital, Brisbane, Australia.

QIMR-Berghofer Medical Research Institute, Brisbane, Australia.

出版信息

J Crohns Colitis. 2022 Aug 4;16(7):1089-1096. doi: 10.1093/ecco-jcc/jjac014.

DOI:10.1093/ecco-jcc/jjac014
PMID:35147694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9351978/
Abstract

BACKGROUND AND AIMS

The erythrocyte sedimentation rate [ESR] as a component of the Truelove and Witts Criteria [TWC] is the traditional inflammatory marker used for the assessment of ulcerative colitis [UC] activity. However, the C-reactive protein [CRP] is preferentially used in contemporary clinical practice. We aimed to determine the equivalent CRP cut-off for an ESR of  >30 mm/h in patients presenting with acute severe UC.

METHODS

Clinical and pathological data were prospectively collected from 163 presentations of severe UC. A CRP cut-off corresponding to an ESR of  >30 mm/h was determined using confusion matrices. A validation cohort of 128 presentations was prospectively collected and analysed.

RESULTS

A CRP cut-off of ≥12 mg/L generated an 85% positive predictive value [PPV] with a sensitivity of 95% and an accuracy of 82% for having a paired ESR of  >30 mm/h. There were no statistically significant differences between groups determined by the traditional ESR versus the new CRP-based criterion in the presenting faecal calprotectin, Mayo endoscopic subscore, or the rates of intravenous corticosteroid therapy failure and colectomy-by-discharge. Applying the CRP  ≥12 mg/L criterion to a validation cohort of 128 presentations generated a PPV of 83% and a sensitivity of 94%.

CONCLUSIONS

The proposed CRP  ≥12 mg/L cut-off is an inclusive, sensitive, and very practical alternative to ESR as part of the TWC for defining UC presentation severity. It demonstrated similar performance characteristics to the classical ESR criterion when used for the assessment of acute UC disease activity. These findings were confirmed in a validation cohort.

摘要

背景与目的

红细胞沉降率(ESR)作为特鲁洛夫和威茨标准(TWC)的组成部分,是用于评估溃疡性结肠炎(UC)活动的传统炎症标志物。然而,C 反应蛋白(CRP)在当代临床实践中更优先使用。我们旨在确定在出现急性重度 UC 的患者中,ESR >30mm/h 对应的 CRP 截断值。

方法

前瞻性收集了 163 例重度 UC 患者的临床和病理数据。使用混淆矩阵确定与 ESR >30mm/h 相对应的 CRP 截断值。前瞻性收集并分析了 128 例就诊患者的验证队列。

结果

CRP 截断值≥12mg/L 对 ESR >30mm/h 具有 85%的阳性预测值(PPV),敏感性为 95%,准确性为 82%。根据传统 ESR 与新的基于 CRP 的标准确定的两组之间,在就诊时粪便钙卫蛋白、Mayo 内镜评分亚量表或静脉皮质类固醇治疗失败和出院时结肠切除的发生率方面,无统计学差异。在 128 例就诊患者的验证队列中应用 CRP≥12mg/L 标准,PPV 为 83%,敏感性为 94%。

结论

所提出的 CRP≥12mg/L 截断值是一种包容性、敏感性和非常实用的替代 ESR 的方法,可作为 TWC 定义 UC 表现严重程度的一部分。当用于评估急性 UC 疾病活动时,它表现出与经典 ESR 标准相似的性能特征。这些发现在验证队列中得到了证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/bddc66cbb5a0/jjac014f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/a951643cb42e/jjac014f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/8a382e2abd7e/jjac014f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/7574ab06b85f/jjac014f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/172dcc22be26/jjac014f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/57380410eb87/jjac014f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/bddc66cbb5a0/jjac014f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/a951643cb42e/jjac014f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/8a382e2abd7e/jjac014f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/7574ab06b85f/jjac014f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/172dcc22be26/jjac014f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/57380410eb87/jjac014f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4658/9351978/bddc66cbb5a0/jjac014f0006.jpg

相似文献

1
Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?炎症标志物在溃疡性结肠炎急性发作中的作用:CRP 水平多高提示重度结肠炎?
J Crohns Colitis. 2022 Aug 4;16(7):1089-1096. doi: 10.1093/ecco-jcc/jjac014.
2
Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.印度炎症性肠病患者粪便钙卫蛋白及其与炎症标志物和内镜检查的相关性
Indian J Gastroenterol. 2015 Nov;34(6):431-5. doi: 10.1007/s12664-015-0608-x. Epub 2015 Nov 21.
3
Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.非侵入性评估在监测炎症性肠病活动中的疗效:中国的一项前瞻性研究。
World J Gastroenterol. 2017 Dec 14;23(46):8235-8247. doi: 10.3748/wjg.v23.i46.8235.
4
Predictive value of faecal calprotectin in ulcerative colitis - single centre experience.粪便钙卫蛋白在溃疡性结肠炎中的预测价值 - 单中心经验。
Ann Med. 2022 Dec;54(1):1570-1577. doi: 10.1080/07853890.2022.2082518.
5
Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.粪便乳铁蛋白、钙卫蛋白、中性粒细胞弹性蛋白酶、C反应蛋白及白细胞计数作为轻至中度溃疡性结肠炎患者黏膜愈合及疾病临床进程的指标:一项前瞻性临床试验的事后分析
J Crohns Colitis. 2016 Jul;10(7):786-94. doi: 10.1093/ecco-jcc/jjw044. Epub 2016 Feb 13.
6
Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.溃疡性结肠炎日本患者实用粪便钙卫蛋白截断值。
World J Gastroenterol. 2018 Oct 14;24(38):4384-4392. doi: 10.3748/wjg.v24.i38.4384.
7
Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.正电子发射断层扫描在溃疡性结肠炎疾病活动评估中的作用:与生物标志物的比较。
Dig Dis Sci. 2018 Jun;63(6):1541-1550. doi: 10.1007/s10620-018-5026-3. Epub 2018 Mar 21.
8
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.粪便钙卫蛋白可预测溃疡性结肠炎患者的黏膜完全愈合,且与溃疡性结肠炎内镜严重程度指数的相关性优于与梅奥内镜亚评分的相关性。
BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7.
9
Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.炎症性肠病患儿肠道炎症的替代标志物
Folia Med (Plovdiv). 2020 Jun 30;62(2):271-275. doi: 10.3897/folmed.62.e47830.
10
Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.常见疾病活动标志物在反映溃疡性结肠炎炎症负担方面的表现
Inflamm Bowel Dis. 2016 Jun;22(6):1384-90. doi: 10.1097/MIB.0000000000000746.

引用本文的文献

1
Association Between Pro-Inflammatory Potential of Diet and Inflammatory Parameters in a Group of Patients with Inflammatory Bowel Disease.一组炎症性肠病患者饮食的促炎潜能与炎症参数之间的关联
Nutrients. 2025 Sep 3;17(17):2858. doi: 10.3390/nu17172858.
2
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.粪钙卫蛋白和C反应蛋白与接受mirikizumab治疗的溃疡性结肠炎患者组织学和内镜检查终点的关联
Crohns Colitis 360. 2025 Jun 14;7(2):otaf043. doi: 10.1093/crocol/otaf043. eCollection 2025 Apr.
3
Increased CT Attenuation of Pericolic Adipose Tissue as a Noninvasive Marker of Disease Severity in Ulcerative Colitis.

本文引用的文献

1
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.第三届欧洲溃疡性结肠炎诊断与管理循证共识。第1部分:定义、诊断、肠外表现、妊娠、癌症监测、手术及回肠储袋疾病
J Crohns Colitis. 2017 Jun 1;11(6):649-670. doi: 10.1093/ecco-jcc/jjx008.
2
Erythrocyte sedimentation rate and C-reactive protein.红细胞沉降率和C反应蛋白
Aust Prescr. 2015 Jun;38(3):93-4. doi: 10.18773/austprescr.2015.034. Epub 2015 Jun 1.
3
Laboratory markers in ulcerative colitis: Current insights and future advances.
结肠周围脂肪组织CT衰减增加作为溃疡性结肠炎疾病严重程度的非侵入性标志物
Korean J Radiol. 2025 May;26(5):411-421. doi: 10.3348/kjr.2024.0857.
4
Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series.在皮质类固醇和英夫利昔单抗难治性急性重症溃疡性结肠炎中使用JAK抑制剂的序贯挽救疗法:病例系列
Therap Adv Gastroenterol. 2025 Mar 30;18:17562848251323511. doi: 10.1177/17562848251323511. eCollection 2025.
5
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study.高剂量阿托伐他汀作为美沙拉嗪辅助治疗对减轻溃疡性结肠炎患者炎症和症状的影响:一项随机对照试验性研究
Front Med (Lausanne). 2025 Jan 22;11:1490178. doi: 10.3389/fmed.2024.1490178. eCollection 2024.
6
Physiological Data Collected From Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares.从可穿戴设备收集的生理数据可识别和预测炎症性肠病发作。
Gastroenterology. 2025 May;168(5):939-951.e5. doi: 10.1053/j.gastro.2024.12.024. Epub 2025 Jan 16.
7
Thermosensitive and pH-responsive quercus infectoria gall-containing gel with long-lasting anti-inflammatory activity for ulcerative colitis.具有持久抗炎活性的用于溃疡性结肠炎的含没食子的热敏和pH响应性凝胶。
Heliyon. 2024 Aug 13;10(19):e36225. doi: 10.1016/j.heliyon.2024.e36225. eCollection 2024 Oct 15.
8
C-Reactive Protein Is Not the Driver Factor in Ulcerative Colitis.C反应蛋白不是溃疡性结肠炎的驱动因素。
Gastroenterol Res Pract. 2024 Oct 1;2024:1386147. doi: 10.1155/2024/1386147. eCollection 2024.
9
Association between dietary inflammatory index and disease activity in patients with ulcerative colitis.饮食炎症指数与溃疡性结肠炎患者疾病活动度的相关性。
Sci Rep. 2024 Sep 17;14(1):21679. doi: 10.1038/s41598-024-73073-9.
10
Acute severe ulcerative colitis trials: the past, the present and the future.急性重度溃疡性结肠炎临床试验:过去、现在和未来。
Gut. 2024 Sep 9;73(10):1763-1773. doi: 10.1136/gutjnl-2024-332489.
溃疡性结肠炎的实验室标志物:当前见解与未来进展
World J Gastrointest Pathophysiol. 2015 Feb 15;6(1):13-22. doi: 10.4291/wjgp.v6.i1.13.
4
How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis.年龄和性别如何影响早期类风湿关节炎患者的红细胞沉降率和C反应蛋白
BMC Musculoskelet Disord. 2014 Nov 6;15:368. doi: 10.1186/1471-2474-15-368.
5
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit.急性重度溃疡性结肠炎抢救治疗的结果:来自英国炎症性肠病审计的数据。
Aliment Pharmacol Ther. 2013 Oct;38(8):935-45. doi: 10.1111/apt.12473. Epub 2013 Sep 4.
6
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.挽救治疗对类固醇难治性急性重度溃疡性结肠炎的疗效:环孢素与英夫利昔单抗。
Aliment Pharmacol Ther. 2013 Aug;38(3):294-302. doi: 10.1111/apt.12375. Epub 2013 Jun 20.
7
Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).2005-2009 年瑞典乌普萨拉地区溃疡性结肠炎的发病和自然史——乌普萨拉地区炎症性肠病队列(ICURE)的结果。
J Crohns Colitis. 2013 Oct;7(9):e351-7. doi: 10.1016/j.crohns.2013.02.006. Epub 2013 Mar 9.
8
Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula.预测重度溃疡性结肠炎患者静脉用环孢素治疗反应的因素:新型预测公式的建立。
Aliment Pharmacol Ther. 2012 Oct;36(8):744-54. doi: 10.1111/apt.12033. Epub 2012 Sep 7.
9
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis.C-反应蛋白(CRP)、红细胞沉降率(ESR)或两者?在小儿溃疡性结肠炎中的系统评价。
J Crohns Colitis. 2011 Oct;5(5):423-9. doi: 10.1016/j.crohns.2011.05.003. Epub 2011 Jun 2.
10
Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers.预测重症溃疡性结肠炎结肠切除术的必要性:对临床参数和现有生物标志物的批判性评估
Gut. 2011 Jan;60(1):3-9. doi: 10.1136/gut.2010.216895.